- Home
- WTRG vs BMRN Comparison
WTRG vs BMRN Comparison
Compare WTRG & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WTRG | BMRN |
|---|---|---|
| Founded | 1901 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2B | 10.5B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | WTRG | BMRN |
|---|---|---|
| Price | $39.71 | $55.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 18 |
| Target Price | $44.33 | ★ $90.00 |
| AVG Volume (30 Days) | 2.2M | ★ 3.1M |
| Earning Date | 11-04-2025 | 10-27-2025 |
| Dividend Yield | ★ 3.45% | N/A |
| EPS Growth | 20.57 | ★ 59.53 |
| EPS | 2.40 | ★ 2.68 |
| Revenue | $2,379,887,000.00 | ★ $3,094,001,000.00 |
| Revenue This Year | $13.46 | $13.32 |
| Revenue Next Year | $5.45 | $7.51 |
| P/E Ratio | ★ $16.56 | $20.86 |
| Revenue Growth | ★ 21.35 | 12.39 |
| 52 Week Low | $33.18 | $50.76 |
| 52 Week High | $42.37 | $73.51 |
Technical Indicators
Market Signals| Indicator | WTRG | BMRN |
|---|---|---|
| Relative Strength Index (RSI) | 51.47 | 57.07 |
| Support Level | $38.12 | $54.51 |
| Resistance Level | $40.25 | $56.45 |
| Average True Range (ATR) | 0.82 | 1.53 |
| MACD | 0.04 | 0.28 |
| Stochastic Oscillator | 66.19 | 81.90 |
Price Performance
Historical ComparisonAbout WTRG Essential Utilities Inc.
Essential Utilities is a Pennsylvania-based holding company for US water, wastewater, and natural gas distribution utilities. The company's water business serves 3 million people in eight states. Its largest service territory is in Pennsylvania, primarily suburban Philadelphia. Its Peoples subsidiary serves more than 740,000 gas distribution customers in Pennsylvania and Kentucky. It completed the sale of its West Virginia gas utility and the bulk of its nonregulated assets in 2024. Essential shareholders would own a 31% stake in American Water Works if the proposed all-stock merger closes in 2027.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.